ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 717

The Burden of Chronic Kidney Disease in Systemic Lupus Erythematosus (SLE): A Nationwide Epidemiologic Study

Arthur Mageau1, Jean Francois Timsit1, Anne Perozziello1, Stephane Ruckly1, Claire Dupuis1, Lila Bouadma1, Thomas Papo1 and Karim Sacre2, 1Université Paris-Diderot, Paris, France, 2Bichat Hospital, Paris Diderot University, Paris, France

Meeting: 2018 ACR/ARHP Annual Meeting

Keywords: Lupus, outcomes, population studies and renal disease

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, October 21, 2018

Title: Systemic Lupus Erythematosus – Clinical Poster I: Clinical Manifestations and Comorbidity

Session Type: ACR Poster Session A

Session Time: 9:00AM-11:00AM

Background/Purpose: Lupus nephritis occurs in about 50% of SLE patients. We aimed to analyze the impact of chronic kidney disease (CKD) on major clinical outcomes in SLE by using a nationwide medico-administrative database.

Methods: We performed a retrospective cohort study to analyse hospital stays’ characteristics of SLE population in France from January 1st, 2009 to December 31st, 2015. We extracted data from the PMSI database (Programme de Médicalisation des Systèmes d’Informations) which compiles hospital discharges of all French healthcare facilities. PMSI uses International Classifications of Diseases 10th revision (ICD-10) to encode diagnosis. All the diagnosis and procedures performed during hospital stays associated with or following a “M32” diagnosis code, which defines the SLE population, were identified. Factors associated with major clinical outcomes such as death, end-stage renal disease (ESRD), septic shock, and cardiovascular event were assessed. Kaplan-Meïer method was used to represent survival without major clinical outcomes according to the presence of CKD (eGFR <60mL/min/1.73m2) at first stay.

Results: From 2009 to 2015, 145 794 hospital stays associated with SLE diagnosis corresponding to 26 320 unique SLE patients were identified. Mean age [SD] at first stay was 46.7 [+/-17.2] and 85.6% were female. Among patients with kidney disease at first stay, 20.8% developed end-stage renal disease (ESRD) during follow up. Overall, from 2009 to 2015, death, septic shock, and cardiovascular event occurred in 6.7%, 4.5% and 10.5% of SLE patients, respectively. CKD identified at first stay in 2009 was significantly associated with the occurrence of death (RR 2.4 [2.0-2.9]), ESRD (RR 4.02 [2.86-5.65]), septic shock (RR 3.1 [2.3-4.2]), and cardiovascular event (RR 1.9 [1.6-2.3]) between 2009 and 2015.

Conclusion: Our results confirm at a nationwide level that CKD is a major risk factor for overall morbidity and mortality in SLE patients, highlighting the need for early pre-CKD lupus nephritis diagnosis.

 

 

Occurrence of death (A), ESRD (B), cardiovascular event (C) and septic shock (D) between 2009 and 2015 according to CKD status (eGFR <60mL/min/1.73m2) at first stay in 2009. Blue lines represent the outcome in patients without CKD at first stay. Red lines represent the outcomes in patients with CKD at first stay

 

 

 


Disclosure: A. Mageau, None; J. F. Timsit, None; A. Perozziello, None; S. Ruckly, None; C. Dupuis, None; L. Bouadma, None; T. Papo, None; K. Sacre, None.

To cite this abstract in AMA style:

Mageau A, Timsit JF, Perozziello A, Ruckly S, Dupuis C, Bouadma L, Papo T, Sacre K. The Burden of Chronic Kidney Disease in Systemic Lupus Erythematosus (SLE): A Nationwide Epidemiologic Study [abstract]. Arthritis Rheumatol. 2018; 70 (suppl 9). https://acrabstracts.org/abstract/the-burden-of-chronic-kidney-disease-in-systemic-lupus-erythematosus-sle-a-nationwide-epidemiologic-study/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2018 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/the-burden-of-chronic-kidney-disease-in-systemic-lupus-erythematosus-sle-a-nationwide-epidemiologic-study/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology